N/A N=54 PeerNaija: A Mobile Health Platform Incentivizing Medication Adherence Among Youth Living With HIV in Nigeria
HIV/AIDS
Primary: Recruitment Rate — 26; 28 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=141 Postoperative Pain Management in Rhinoplasty
Pain, Postoperative
Primary: Pain Intensity Visual Analog Scale (VAS)- 0-100 (0- no Pain and 100- Most Severe Pain) — 44; 41 score on a scale — p=0.156
N/A N=41 Eating Mindfully to Prevent Weight Regain
Weight Loss · Weight Gain · Eating Behavior
Primary: Changes in Body Weight — 2.45; -3.78 kilograms — p=<0.001
Phase 3 N=60 Treating PCOS With Semaglutide vs Active Lifestyle Intervention
PCOS · Adolescent Obesity · NAFLD
Primary: Change in Hepatic Fat Fraction — -1.41; -1.84 Change in percentage of liver fat
N/A N=48 Intervention for Victimized Youth
Victimization
Primary: Change in Social-emotional Distress — 1.09; 1.07; 0.97; 1.00 mean item score on a scale — p=0.646
Phase 2 N=20 Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Recurrent Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8
Primary: Proportion of Participants With Progression Free Survival (PFS) — 0.6; 0.429 proportion of participants
Phase 4 N=36 MIcrovascular dysfuNction In Moderate-severe Psoriasis
Psoriasis · Cardiovascular Disease
Primary: Change in Global Coronary Flow Reserve (CFR) After 6 Months of Therapy With Tildrakizumab — -0.03 CFR Ratio
N/A N=1,985 Evaluating Cross-Cutting Prevention at the U.S. Air Force Academy
Sexual Assault · Alcohol Misuse
Primary: Self-reported Sexual Assault Victimization — 88; 63; 92; 69 Participants
N/A N=26 Novel EEG Coherence Biomarkers for PTSD Assessment
PTSD
Primary: Coherence — 0.28; 0.27; 0.27 Coherence — p=0.01
Phase 2 N=60 Evolocumab in Acute Coronary Syndrome
Acute Coronary Syndrome
Primary: Percent Change in LDL-Cholesterol — -68.78; -27.58 percent change
N/A N=59 A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment
Anxiety Disorders
Primary: Screen for Child Anxiety Related Emotional Disorders - Parent Version at Posttreatment — 35; 30 units on a scale
N/A N=8 Incentivizing Lifestyle Modification to Reduce Disease Burden
Obesity · Diabetes Mellitus
Primary: Miles Walked — 1.1; 6.06 Miles — p=0.32
N/A N=437 A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation
Tobacco Use
Primary: Number of Participants With Cigarette Abstinence — 102; 38; 112; 54 Participants — p=.036
N/A N=299 Implementing mHealth for Schizophrenia in Community Mental Health Settings
Schizophrenia
Primary: Patient Health Questionnaire (PHQ)-9 — 11.6; 10.7; 9.6; 10.2 Scores on scale — p=.06
Phase 4 N=20 INF108F in Infants With Food Protein Induced Proctocolitis
Infant Development · Gut Microbiome · Food Protein Induced Allergic Proctocolitis
Primary: Changes to Gut Microbiome Composition — 42.816; -12.413 Change in %B.infantis reads (Day 28-BL) — p=0.154